RIVA RIVAROXABAN
Identification of Riva Rivaroxaban
| No description |
Google image searchProduct monograph
Active ingredient
rivaroxaban, 15 MG
DIN: 02540851
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: LABORATOIRE RIVA INC.
Date: 06-NOV-2023
ATC:
- B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
- B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
- B01AF — Direct factor Xa inhibitors (ATC, ATC/DDD)
- B01AF01 — RIVAROXABAN (ATC/DDD)
Reference brand drug: Xarelto
Pharmaceutical standard: MFR
